These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 15451501

  • 1. Taking inventory: antibacterial agents currently at or beyond phase 1.
    Bush K, Macielag M, Weidner-Wells M.
    Curr Opin Microbiol; 2004 Oct; 7(5):466-76. PubMed ID: 15451501
    [Abstract] [Full Text] [Related]

  • 2. New agents in development for the treatment of bacterial infections.
    Abbanat D, Morrow B, Bush K.
    Curr Opin Pharmacol; 2008 Oct; 8(5):582-92. PubMed ID: 18761107
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
    Garrison MW, Neumiller JJ, Setter SM.
    Clin Ther; 2005 Jan; 27(1):12-22. PubMed ID: 15763603
    [Abstract] [Full Text] [Related]

  • 7. The antimicrobial armamentarium: evaluating current and future treatment options.
    Bosso JA.
    Pharmacotherapy; 2005 Oct; 25(10 Pt 2):55S-62S. PubMed ID: 16178676
    [Abstract] [Full Text] [Related]

  • 8. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ, Bradford PA.
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [Abstract] [Full Text] [Related]

  • 9. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE, Rybak MJ.
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tigecycline: a new glycylcycline for treatment of serious infections.
    Noskin GA.
    Clin Infect Dis; 2005 Sep 01; 41 Suppl 5():S303-14. PubMed ID: 16080069
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New developments in carbapenems.
    Kattan JN, Villegas MV, Quinn JP.
    Clin Microbiol Infect; 2008 Dec 01; 14(12):1102-11. PubMed ID: 19076841
    [Abstract] [Full Text] [Related]

  • 16. Antibacterial agents (oxazolidinones, quinolones, macrolides and new agents): patent highlights June to December 2000.
    Phillips OA, Matowe WC.
    Curr Opin Investig Drugs; 2001 Jun 01; 2(6):745-51. PubMed ID: 11572651
    [Abstract] [Full Text] [Related]

  • 17. Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria.
    Appelbaum PC, Jacobs MR.
    Curr Opin Microbiol; 2005 Oct 01; 8(5):510-7. PubMed ID: 16098786
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives.
    Liu J, Cao R, Wu Q, Ma C, Wang Z, Peng W, Song H.
    Eur J Med Chem; 2009 Apr 01; 44(4):1737-44. PubMed ID: 18450331
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.